The Potential Impact of GLP-1 Receptor Agonists on Exacerbation Risk in Patients with COPD and Type 2 Diabetes: A Real-World Population-Based Observational Study

Alcázar-Navarrete B, Heatley H, Kaplan A, Tan LT, Koh MS, Sattar N, Townend J, Skinner D, Carter V, Price D

Pragmatic and Observational Research 2026, 17:550543

Published Date: 30 January 2026